Translational cancer medicine happens at the interface between the lab and the clinic. It transitions basic science breakthroughs to the practice of medicine and uses clinical outcome to feed back into basic research. In order to make any advances in translational cancer medicine, there must be open lines of communication between researchers and clinicians.
